Abstract Objective To investigate the changes and clinical significance of biomarker fecal bile acids (BA) in children with Henoch-Schönlein purpura (HSP). Methods Nineteen children with HSP and twenty-seven healthy children were enrolled in this study. The stool samples were obtained at the acute and remission phases. Fecal BA levels were measured by high performance liquid chromatography mass spectrometry (HPLC-MS). Results The fecal cholic acid level in the HSP remission group was significantly higher than in the HSP acute group and the healthy control group (P < 0.016). The fecal chenodeoxycholic acid level in the HSP remission group was significantly higher than in the healthy control group (P < 0.016). The levels of fecal secondary colonic bile acids, deoxycholic acid and lithocholic acid, in the HSP acute and remission groups were significantly lower than in the healthy control group(P < 0.05, P < 0.016 respectively). No significant differences were found in the levels of fecal urosodeoxycholic acid among the three groups (P > 0.05). Conclusions Fecal secondary colonic bile acids, deoxycholic acid and lithocholic acid, are in decrease in children with HSP at the acute stage, which may be involved in the pathogenesis and treatment outcomes of HSP.
HU Hong-Wei,DUAN Jiang,ZHAO Bo et al. Significance of detection of biomarker fecal bile acids in the diagnosis and treatment of childhood Henoch-Schönlein purpura[J]. CJCP, 2016, 18(6): 517-521.
HU Hong-Wei,DUAN Jiang,ZHAO Bo et al. Significance of detection of biomarker fecal bile acids in the diagnosis and treatment of childhood Henoch-Schönlein purpura[J]. CJCP, 2016, 18(6): 517-521.
He X, Zhao Y, Li Y, et al. Serum amyloid A levels associated with gastrointestinal manifestations in Henoch-Schönlein purpura[J]. Inflammation, 2012, 35(4): 1251-1255.
Yang YH, Yu HH, Chianq BL. The diagnosis and classification of Henoch-Schönlein purpura: an updated review[J]. Autoimmun Rev, 2014, 13(4-5): 355-358.
[5]
Ou J, DeLany JP, Zhang M, et al. Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations[J]. Nutr Cancer, 2012, 64(1): 34-40.
[6]
Duboc H, Rainteau D, Rajca S, et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome[J]. Neuroqastroenterol Motil, 2012, 24(6): 513-520.
[7]
Duboc H, Rajca S, Rainteau D, et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases[J]. Gut, 2013, 62(4): 531-539.
[8]
Weingarden AR, Dosa PI, DeWinter E, et al. Changes in colonic bile acid composition following fecal microbiota transplantation are sufficient to control clostridium difficile germination and growth[J]. PLoS One, 2016, 11(1): e0147210.
Zhang Y, Guo X, Guo J, et al. Lactobacillus casei reduces susceptibility to type 2 diabetes via microbiota-mediated body chloride ion influx[J]. Sci Rep, 2014, 4: 5654.
[11]
John C, Werner P, Worthmann A, et al. A liquid chromatography-tandem mass spectrometry-based method for the simultaneous determination of hydroxy sterols and bile acids[J]. J Chromatogr A, 2014, 1371: 184-195.
[12]
Chen T, Jia RZ, Guo ZP, et al. Elevated serum interleukin-33 levels in patients with Henoch-Schönlein purpura[J]. Arch Dermatol Res, 2013, 305(2): 173-177.
[13]
Chen O, Zhu XB, Ren H, et al. The imbalance of Th17/Treg in Chinese children with Henoch-schönlein purpura[J]. Int Immunopharmacol, 2013, 16(1): 67-71.
[14]
López-Mejías R, Genre F, Pérez BS, et al. Association of HLA-B*41:02 with Henoch-Schönlein Purpura (IgA Vasculitis) in Spanish individuals irrespective of the HLA-DRB1 status[J]. Arthritis Res Ther, 2015, 17: 102.
[15]
Yang YH, Tsai IJ, Chang CJ, et al. The interaction between circulating complement proteins and cutaneous microvascular endothelial cells in the development of childhood Henoch-Schönlein Purpura[J]. PLoS One, 2015, 10(3): e0120411.
Devlin AS, Fischbach MA. A biosynthetic pathway for a prominent class of microbiota-derived bile acids[J]. Nat Chem Biol, 2015, 11(9): 685-690.
[21]
Chiang JY. Bile acids: regulation of synthesis[J]. J Lipid Res, 2009, 50(10): 1955-1966.
[22]
Houten SM, Watanabe M, Auwerx J. Endocrine functions of bile acids[J]. EMBO J, 2006, 25(7): 1419-1425.
[23]
Bajor A, Gillberg PG, Abrahamsson H. Bile acids: short and long term effects in the intestine[J]. Scand J Gastroenterol, 2010, 45(6): 645-664.
[24]
Keating N, Keely SJ. Bile acids in regulation of intestinal physiology[J]. Curr Gastroenterol Rep, 2009, 11(5): 375-382.
[25]
Barcelo A, Claustre J, Toumi F, et al. Effect of bile salts on colonic mucus secretion in isolated vascularly perfused rat colon[J]. Dig Dis Sci, 2001, 46(6): 1223-1231.
[26]
Strauch ED, Yamaquchi J, Bass BL, et al. Bile salts regulate intestinal epithelial cell migration by nuclear factor-kappa B-induced expression of transforming growth factor-beta[J]. J Am Coll Surg, 2003, 197(6): 974-984.
[27]
Mühlbauer M, Allard B, Bosserhoff AK, et al. Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells[J]. Am J Physiol Gastrointest Liver Physiol, 2004, 286(6): G1000-G1008.
[28]
Münch A, Ström M, Söderholm JD. Dihydroxy bile acids increase mucosal permeability and bacterial uptake in human colon biopsies[J]. Scand J Gastroenterol, 2007, 42(10): 1167-1174.
[29]
Münch A, Söderholm JD, Ost A, et al. Low levels of bile acids increase bacterial uptake in colonic biopsies from patients with collagenous colitis in remission[J]. Aliment Pharmacol Ther, 2011, 33(8): 954-960.
[30]
Keitel V, Donner M, Winandy S, et al. Expression and function of the bile acid receptor TGR5 in Kupffer cells[J]. Biochem Biophys Res Commun, 2008, 372(1): 78-84.
[31]
Duboc H, Rajca S, Rainteau D, et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases[J]. Gut, 2013, 62(4): 531-539.
[32]
Nalbantoglu S, Tabel Y, Mir S, et al. Lack of association between macrophage migration inhibitory factor gene promoter (-173 G/C) polymorphism and childhood Henoch-Schönlein purpura in Turkish patients[J]. Cytokine, 2013, 62(1): 160-164.
[33]
Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria[J]. J Lipid Res, 2006, 47(2): 241-259.
[34]
Miyata M, Hayashi K, Yamakawa H, et al. Antibacterial drug treatment increases intestinal bile acid absorption via elevated levels of ileal apical sodium-dependent bile acid transporter but not organic solute transporter α protein[J]. Biol Pharm Bull, 2015, 38(3): 493-496.
